Trisomy 12 CLLs progress through NOTCH1 mutations

Leukemia

Volumn 27, Issue 3, 2013, Pages 740-743

  Balatti, V ^a   Lerner, S ^b   Rizzotto, L ^c   Rassenti, L Z ^d   Bottoni, A ^a   Palamarchuk, A ^a   Cascione, L ^a,e   Alder, H ^a   Keating, M J ^b   Kipps, T J ^d   Pekarsky, Y ^a   Croce, C M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF FERRARA   (Italy)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH1 RECEPTOR; PROTEIN KINASE ZAP 70;

ALLELE; CANCER RECURRENCE; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRISOMY 12;

CHROMOSOMES, HUMAN, PAIR 12; DISEASE PROGRESSION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MUTATION; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, NOTCH1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRISOMY;

EID: 84875212220     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.239     Document Type: Letter

References (15)

1. Sgambati MLM, Devesa S. Chronic Lymphocytic Leukemia, Epidemiological, Familiar, and Genetic Aspects. Bruce Cheson, Ed Marcel Dekker, Inc: New York, 2001, pp 33-62.
2. Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med 2011; 208: 1389-1401.
3. Puente XS, Pinyol M, Quesada V, Conde L, Ordonez GR, Villamor N et al. Wholegenome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011; 475: 101-105.
4. Balatti V, Bottoni A, Palamarchuk A, Alder H, Rassenti LZ, Kipps TJ et al. NOTCH1 mutations in CLL associated with trisomy 12. Blood 2012; 119: 329-331.
5. Aster JC, Blacklow SC, Pear WS. Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies. J Pathol 2011; 223: 262-273.
6. Koch U, Radtke F. Notch in T-ALL: new players in a complex disease. Trends Immunol 2011; 32: 434-442.
7. Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci USA 2006; 103: 18261-18266.
8. Pekarsky Y, Palamarchuk A, Maximov V, Efanov A, Nazaryan N, Santanam U et al. Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL. Proc Natl Acad Sci USA 2008; 105: 19643-19648.
9. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P et al. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 1995; 6: 387-400.
10. Mullican SE, Zhang S, Konopleva M, Ruvolo V, Andreeff M, Milbrandt J et al. Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. Nat Med 2007; 13: 730-735.
11. Tanoue T, Moriguchi T, Nishida E. Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5. J Biol Chem 1999; 274: 19949-19956.
12. Stawowczyk M, Van Scoy S, Kumar KP, Reich NC. The interferon stimulated gene promotes apoptosis. J Biol Chem 2011; 286: 7257-7266.
13. Huang RP, Fan Y, de Belle I, Niemeyer C, Gottardis MM, Mercola D et al. Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer 1997; 72: 102-109.
14. Shields JM, Christy RJ, Yang VW. Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J Biol Chem 1996; 271: 20009-20017.
15. Xiao S, Li D, Zhu HQ, Song MG, Pan XR, Jia PM et al. RIG-G as a key mediator of the antiproliferative activity of interferon-related pathways through enhancing p21 and p27 proteins. Proc Natl Acad Sci USA 2006; 103: 16448-16453.